Back to Results
First PageMeta Content
Nephrology / Angiotensin II receptor antagonists / Federal assistance in the United States / Healthcare reform in the United States / Medicare / Valsartan / Dialysis / Comorbidity / Chemistry / Medicine / Health


Use and costs of ACEIs, ARBs, and Renin Inhibitors in U.S. adult dialysis patients with Medicare Part D in 2007 Wendy St. Peter, PharmD1,2, Christopher Powers, PharmD3, Eric Weinhandl, MS1, Benjamin Howell, PhD3, James E
Add to Reading List

Document Date: 2010-12-07 12:50:00

Open Document

File Size: 298,31 KB

Share Result on Facebook

Company

ESRD Networks / First DataBank / /

Country

United States / /

Currency

USD / /

Facility

CMS’ Chronic Condition Warehouse / /

MedicalCondition

transient ischemic attack / primary ESRD / congestive heart failure / hypertension / peripheral arterial disease / atrial fibrillation / ESRD / cerebrovascular accident / Cystic kidney / mean ESRD / acute myocardial infarction / /

MedicalTreatment

dialysis / bypass / /

Organization

office of Research / Development / and Information Introduction / Minneapolis Medical Research Foundation / Medicare / /

Person

Benjamin Howell / Christopher Powers / Wendy St. Peter / James Ebben / Eric Weinhandl / /

Product

Telmisartan / Ramipril / Valsartan / Irbesartan / Captopril / Lisinopril / Losartan / Quinapril / /

ProvinceOrState

Minnesota / Alaska / /

Technology

dialysis / /

SocialTag